Plain-English translation of NCT06342440 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Researchers are developing a new blood test that could detect advanced colon polyps and early colorectal cancer before they become life-threatening. The test works by analyzing tiny pieces of genetic material called microRNA in your blood—markers that are present when precancerous growths or cancer develop. This study will enroll 2,000 people to help identify which blood markers work best for catching these dangerous changes early.
Current colon cancer screening methods either miss dangerous precancerous polyps or require uncomfortable invasive procedures that many people avoid. This medication-free blood test aims to fill that gap by offering a simple, non-invasive way to catch cancer and its warning signs before they become advanced, when treatment is most effective.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will donate a blood sample, ideally at the time of or shortly after your colonoscopy. Researchers will analyze your blood for the genetic markers they are studying. You may be placed into one of several groups based on your colonoscopy results—such as having no polyps, small low-risk polyps, advanced polyps, or cancer—which helps scientists understand how the blood test performs across different situations.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States
China
Italy
Japan